Kingworld Medicines Group Ltd. issued a supplemental announcement correcting a typographical error regarding the number of shares available for future grants under the 2025 Share Award Scheme. The corrected figure is 58,792,400 shares. The announcement also provided further information on the vesting period for awarded shares, highlighting that a shorter vesting period of less than 12 months from the grant date was deemed appropriate based on the grantees' performance and contributions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.